DaShenLin Pharma: Retail Chain of Med, Trad. Chin., Equip., etcLooking back at a snapshop of DaShenLin Pharma's balance sheet, this company seems to have carved a niche market in regular medicine, traditional Chinese medicine products, medical equipment, personal care and household items.
Their products are flying off the shelves as it positioned itself as a
DaShenLin Pharmaceutical Group Co., Ltd. Class A
No trades
No trades
Peers for comparison
1.26 CNY
1.24 B CNY
27.50 B CNY
390.88 M
Last report date
—
Report period
—
EPS
—
Revenue
—
Company info
Sector
Industry
CEO
Guo Qiang Ke
Website
Headquarters
Guangzhou
Founded
1999
IPO date
Jul 31, 2017
ISIN
CNE100002RG2
FIGI
BBG00GBVZR14
Identifiers
ISIN CNE100002RG2
DaShenLin Pharmaceutical Group Co., Ltd. engages in the chain retail business of medicines, chinese herbal medicine slices, ginseng and antler tonics, health products, medical devices, personal care products, household products. The company was founded by Yun Feng Ke, Kang Bao Ke, Jin Long Ke and Chao Zhu Zou on February 12, 1999 and is headquartered in Guangzhou, China.
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.99%
Market value3.60 M
Weight0.98%
Market value3.29 M
Weight1.01%
Market value1.40 M
Explore more ETFs
Frequently asked questions
Today, 603233 trades at 20.72 CNY.
For broader market analysis, dive into the technicals on the DaShenLin Pharmaceutical Group Co., Ltd. Class A stock price chart and read the latest 603233 news:
– DaShenLin Pharmaceutical Q3 Net Profit Up 21.7% Y/Y
– DaShenLin Pharmaceutical H1 Net Profit Up 16.1% Y/Y
– DaShenLin Pharmaceutical 2025 Net Profit Up 35.0% Y/Y
For broader market analysis, dive into the technicals on the DaShenLin Pharmaceutical Group Co., Ltd. Class A stock price chart and read the latest 603233 news:
– DaShenLin Pharmaceutical Q3 Net Profit Up 21.7% Y/Y
– DaShenLin Pharmaceutical H1 Net Profit Up 16.1% Y/Y
– DaShenLin Pharmaceutical 2025 Net Profit Up 35.0% Y/Y
Markets don't sleep, here's what's going on with 603233 at the moment:
– DaShenLin Pharmaceutical Q3 Net Profit Up 21.7% Y/Y
– DaShenLin Pharmaceutical H1 Net Profit Up 16.1% Y/Y
– DaShenLin Pharmaceutical 2025 Net Profit Up 35.0% Y/Y
See more updates in real-time with our News Flow.
– DaShenLin Pharmaceutical Q3 Net Profit Up 21.7% Y/Y
– DaShenLin Pharmaceutical H1 Net Profit Up 16.1% Y/Y
– DaShenLin Pharmaceutical 2025 Net Profit Up 35.0% Y/Y
See more updates in real-time with our News Flow.
DaShenLin Pharmaceutical Group Co., Ltd. Class A is scheduled to release its next earnings report on Apr 29, 2027.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
603233 stock is 4.60% volatile and has beta coefficient of 0.17.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like 603233 are typically less volatile than smaller companies
Track every detail on DaShenLin Pharmaceutical Group Co., Ltd. Class A stock chart and check out the list of the most volatile stocks — is DaShenLin Pharmaceutical Group Co., Ltd. Class A there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like 603233 are typically less volatile than smaller companies
Track every detail on DaShenLin Pharmaceutical Group Co., Ltd. Class A stock chart and check out the list of the most volatile stocks — is DaShenLin Pharmaceutical Group Co., Ltd. Class A there?
To understand the 603233 stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −2.06%
– 1 week — +10.76%
– 1 month — +13.96%
603233 all-time low was 11.00 CNY (Jul 31, 2017), and its highest price is 61.63 CNY (Jan 25, 2021). Find more dynamics in the Stock Heatmap and on the DaShenLin Pharmaceutical Group Co., Ltd. Class A stock chart.
– 1 day — −2.06%
– 1 week — +10.76%
– 1 month — +13.96%
603233 all-time low was 11.00 CNY (Jul 31, 2017), and its highest price is 61.63 CNY (Jan 25, 2021). Find more dynamics in the Stock Heatmap and on the DaShenLin Pharmaceutical Group Co., Ltd. Class A stock chart.
DaShenLin Pharmaceutical Group Co., Ltd. Class A market capitalization is 24.05 B, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from DaShenLin Pharmaceutical Group Co., Ltd. Class A stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how DaShenLin Pharmaceutical Group Co., Ltd. Class A stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from DaShenLin Pharmaceutical Group Co., Ltd. Class A stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how DaShenLin Pharmaceutical Group Co., Ltd. Class A stacks up against other companies
The safest way to buy DaShenLin Pharmaceutical Group Co., Ltd. Class A stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade 603233 directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade 603233 directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 5, 2026, the company has 41.14 K employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
DaShenLin Pharmaceutical Group Co., Ltd. Class A pays dividends, but whether it is a “good” dividend stock depends on its yield and stability rather than dividends alone.
Its recent dividend yield was around 4.71%, with a payout ratio of 76.07%, compared to 4.12% and 77.00% in the previous period.
What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance
Explore all this in DaShenLin Pharmaceutical Group Co., Ltd. Class A financials.
Its recent dividend yield was around 4.71%, with a payout ratio of 76.07%, compared to 4.12% and 77.00% in the previous period.
What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance
Explore all this in DaShenLin Pharmaceutical Group Co., Ltd. Class A financials.
Investing in DaShenLin Pharmaceutical Group Co., Ltd. Class A depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study DaShenLin Pharmaceutical Group Co., Ltd. Class A financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our 603233 technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
First, study DaShenLin Pharmaceutical Group Co., Ltd. Class A financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our 603233 technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
DaShenLin Pharmaceutical Group Co., Ltd. Class A stock ticker depends on the exchange where it’s listed. On the SSE, its primary exchange, DaShenLin Pharmaceutical Group Co., Ltd. Class A stocks trade under the symbol 603233.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
603233 earnings for the last quarter are 0.32 CNY per share, whereas the estimation was 0.34 CNY, resulting in a −6.31% surprise. The estimated earnings for the next quarter are 0.16 CNY per share.
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in DaShenLin Pharmaceutical Group Co., Ltd. Class A financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in DaShenLin Pharmaceutical Group Co., Ltd. Class A financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
DaShenLin Pharmaceutical Group Co., Ltd. Class A revenue for the last quarter amounts to 7.32 B CNY despite the estimated figure of 7.44 B CNY. In the next quarter revenue is expected to reach 8.36 B CNY.
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in DaShenLin Pharmaceutical Group Co., Ltd. Class A financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in DaShenLin Pharmaceutical Group Co., Ltd. Class A financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track DaShenLin Pharmaceutical Group Co., Ltd. Class A financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
603233 net income for the last quarter is 344.15 M CNY, while the quarter before that showed 415.56 M CNY of net income which accounts for −17.18% change.
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in DaShenLin Pharmaceutical Group Co., Ltd. Class A financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in DaShenLin Pharmaceutical Group Co., Ltd. Class A financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
DaShenLin Pharmaceutical Group Co., Ltd. Class A does pay dividends, which are distributed semi-annually. The most recent dividend per share was 0.41 CNY, with a trailing twelve-month (TTM) dividend yield of 4.39%.
Explore more details on DaShenLin Pharmaceutical Group Co., Ltd. Class A dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
Explore more details on DaShenLin Pharmaceutical Group Co., Ltd. Class A dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
603233 reached its all-time high of 61.63 CNY on Jan 25, 2021. Its all-time low was 11.00 CNY and was reached on Jul 31, 2017.
Explore the DaShenLin Pharmaceutical Group Co., Ltd. Class A stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the DaShenLin Pharmaceutical Group Co., Ltd. Class A stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Analyst forecasts suggest a price range between 15.00 CNY and 26.50 CNY for 603233, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
